ARTICLE | Clinical News
Afluria Quadrivalent: Phase III data
October 3, 2016 7:00 AM UTC
CSL’s Seqirus unit reported data from a double-blind, U.S. Phase III trial in 3,484 adults ages >=18 showing that intramuscular Afluria Quadrivalent met the primary endpoint of non-inferiority to Aflu...